Application of metallothionein composite preparation in preparation of drugs for acupoint intervened treatment of cerebral apoplexy sequelae

A technology for sequelae of cerebral apoplexy and metallothionein, which is applied in the field of medical application of metallothionein, can solve problems such as long recovery time, achieve the effects of improving physical signs, restoring the brain nervous system, and preventing recurrence and progression of diseases

Inactive Publication Date: 2015-03-11
刘添如
View PDF0 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Anticoagulation, promoting blood circulation and removing blood stasis, aromatic rejuvenation for rehabilitation treatment, long recovery time

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0043] Acupoint Interventional Therapy for Sequelae of Cerebral Apoplexy:

[0044] Metallothionein (MT) is a lyophilized rabbit liver metallothionein protein that is obtained by separating and purifying rabbit liver treated by a special induction technology.

[0045] The weight ratio of metallothionein compound preparation is 50% of MT-I, 50% of MT-II, and the freeze-dried powder of rabbit liver metallothionein with a purity greater than 95%.

[0046] Rabbit liver metallothionein (MT) compound preparation solvent: sterile water for injection.

[0047] Rabbit liver metallothionein (MT) compound preparation freeze-dried powder and solvent dilution ratio: 5-10mg / ml. (5-10 mg metallothionein per ml solution).

[0048] Acupoint selection method: Main points: Yamen Toufengfu, auxiliary points, Xinshu, Guanyuan, Neiguan, Juegu, balance dysfunction plus acupuncture Changqiang.

[0049] usage:

[0050] A. Draw up the metallothionein (MT) dilution with a 2-5ml disposable syringe.

...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses an application of a metallothionein composite preparation in the preparation of drugs for acupoint intervened treatment of cerebral apoplexy sequelae. The metallothionein composite preparation is lyophilized powder cony liver metallothionein with the purity of above 95%, and comprises 50wt% of MT-I and 50wt% of MT-II. The metallothionein composite preparation has very substantial integral organ tissue metabolism improvement and brain injury restoration effects in the treatment process of the cerebral apoplexy sequelae, accelerates the metabolism and purification of brain environment, accelerates the restoration of injured brain nerve cells, recovers the normal differentiation of the brain nerve cells, improves the motion and language nerve system signs controlled by the brain nerve cells, fundamentally improves the unsmooth speech, limb disturbance and other symptoms of the cerebral apoplexy sequelae, and effectively prevents disease recurrence. The metallothionein composite preparation has the advantages of short patient rehabilitation time, high clinic cure rate, and popularization deserving.

Description

technical field [0001] The invention belongs to the field of medical applications of metallothionein, in particular to the application of a compound preparation of metallothionein (MT) as a medicine for the preparation of acupoint interventional treatment of sequelae of cerebral apoplexy. Background technique [0002] At present, in the treatment of sequelae of cerebral apoplexy, Western medicine mainly uses oral or injectable drugs to prevent platelet aggregation, and calcium ion antagonists: captopril, aspirin, clopidogrel, nimodipine, mannitol, and cerebrolysin. , by dilating blood vessels, anticoagulation, and improving blood supply to brain tissue. It is an effective method to alleviate the symptoms of stroke sequelae and reduce the high recurrence rate. While passively recovering from exercise, reliable drug treatment can be used to effectively treat basic lesions such as atherosclerotic plaque formation and high blood viscosity, which are the causes of stroke, and pre...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K38/17A61P9/10
CPCA61K38/17
Inventor 刘添如
Owner 刘添如
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products